Related references
Note: Only part of the references are listed.Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes
LL Sahuque et al.
PSYCHOPHARMACOLOGY (2006)
Corticotropin-releasing factor from the rat brain measured by protein immunoblot
EG Meloni et al.
PEPTIDES (2005)
Cardioprotection by ε-protein kinase C activation from ischemia -: Continuous delivery and antiarrhythmic effect of an ε-protein kinase C-activating peptide
K Inagaki et al.
CIRCULATION (2005)
A role for corticotropin-releasing factor in repeated cold stress-induced anxiety-like behavior during forced swimming and elevated plus-maze tests in mice
H Nishikawa et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2004)
Differential regulation of behavioral, genomic and neuroendocrine responses by CRF infusions in rats
BM Campbell et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2004)
Role of different brain structures in the behavioural expression of WIN 55,212-2 withdrawal in mice
A Castañé et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Promoter analysis of human corticotropin-releasing factor (CRF) type 1 receptor and regulation by CRF and urocortin
KL Parham et al.
ENDOCRINOLOGY (2004)
Tissue plasminogen activator promotes the effects of corticotropin-releasing factor on the amygdala and anxiety-like behavior
T Matys et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress
MB Müller et al.
NATURE NEUROSCIENCE (2003)
A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference
DA Rubinson et al.
NATURE GENETICS (2003)
Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties
R Rupprecht
PSYCHONEUROENDOCRINOLOGY (2003)
Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders
A Holmes et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
Move over protein kinase C, you've got company: Alternative cellular effectors of diacylglycerol and phorbol esters
N Brose et al.
JOURNAL OF CELL SCIENCE (2002)
Adrenal insufficiency in the critically ill - A new look at an old problem
PE Marik et al.
CHEST (2002)
Regulation of gene promoters of hypothalamic peptides
J Peter et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2002)
Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase Cε
CW Hodge et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Novel glucocorticoid and cAMP interactions on the CRH gene promoter
BR King et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2002)
Role of protein kinase C in control of ethanol-modulated β-endorphin release from hypothalamic neurons in primary cultures
A De et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult
C Gross et al.
NATURE (2002)
Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression
JMHM Reul et al.
CURRENT OPINION IN PHARMACOLOGY (2002)
Ethanol regulates calcium channel subunits by protein kinase C δ-dependent and -independent mechanisms
HJ Walter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates
KE Habib et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)